COVID-19 Vaccination Status Among Korean Pediatric Population With Comorbiditiesopen access
- Authors
- Shin, Areum; Kim, Dong Wook; Kim, Young-Eun; Kim, Doo Ri; Jung, Jaehun; Kim, Yae-Jean
- Issue Date
- Aug-2023
- Publisher
- KOREAN ACAD MEDICAL SCIENCES
- Keywords
- COVID-19 Vaccine; Children; Comorbidity
- Citation
- JOURNAL OF KOREAN MEDICAL SCIENCE, v.38, no.32, pp.1 - 10
- Journal Title
- JOURNAL OF KOREAN MEDICAL SCIENCE
- Volume
- 38
- Number
- 32
- Start Page
- 1
- End Page
- 10
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/89065
- DOI
- 10.3346/jkms.2023.38.e248
- ISSN
- 1011-8934
- Abstract
- The pediatric population with comorbidities is a high-risk group for severe coronavirus disease 2019 (COVID-19). As of January 2023, the COVID-19 vaccination rate for at least two doses among Korean children 5-11 years is low at 1.1%. We summarized the COVID-19 vaccination status for the pediatric population (5-17 years) with comorbidities through July 2022 using the National Health Insurance Service database. Pediatric patients with comorbidities had higher vaccination rates than the general pediatric population (2.4% vs. 1.1% in 5-11-year-olds [P < 0.001], 76.5% vs. 66.1% in 12-17-year-olds [P < 0.001]). However, there were substantial differences according to comorbidity category, and the 2-dose vaccination rate was lowest among children with immunodeficiency in all age groups (1.1% in 5-11-year-olds, 51.2% in 12-17-year-olds). The COVID-19 vaccination rate among Korean children has remained stagnant at a low proportion despite ongoing outreach. Thus, more proactive strategies are needed alongside continuous surveillance.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의예과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/89065)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.